Scarica l'app Stockscreener
7.24
4.93%
0.34
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.90
Aprire:
$6.97
Volume 24 ore:
1.40M
Relative Volume:
1.16
Capitalizzazione di mercato:
$412.64M
Reddito:
$5.82M
Utile/perdita netta:
$71.18M
Rapporto P/E:
7.2603
EPS:
0.9972
Flusso di cassa netto:
$-84.30M
1 W Prestazione:
+12.77%
1M Prestazione:
+10.53%
6M Prestazione:
+41.13%
1 anno Prestazione:
+15.47%
Intervallo 1D:
$6.94
$7.30
Intervallo di 1 settimana:
$6.295
$7.30
Portata 52W:
$4.00
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Nome
Abeona Therapeutics Inc
Settore
Industria
Telefono
646-813-4701
Indirizzo
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Compare ABEO vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
7.24 | 349.38M | 5.82M | 71.18M | -84.30M | 0.9972 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-03-05 | Iniziato | Oppenheimer | Outperform |
| 2024-07-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-30 | Iniziato | Stifel | Buy |
| 2020-11-11 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Iniziato | B. Riley FBR | Buy |
| 2020-02-10 | Iniziato | SVB Leerink | Outperform |
| 2019-12-10 | Ripresa | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Downgrade | Maxim Group | Buy → Hold |
| 2019-08-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Downgrade | Mizuho | Buy → Neutral |
| 2019-06-27 | Iniziato | Mizuho | Buy |
| 2018-10-12 | Iniziato | Mizuho | Buy |
| 2018-06-05 | Iniziato | Seaport Global Securities | Buy |
| 2017-11-08 | Iniziato | SunTrust | Buy |
| 2017-10-16 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-11 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Iniziato | Citigroup | Buy |
| 2017-10-05 | Reiterato | Maxim Group | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-07-18 | Reiterato | Maxim Group | Buy |
| 2017-06-22 | Ripresa | Jefferies | Buy |
| 2017-01-06 | Iniziato | Jefferies | Buy |
| 2016-09-29 | Reiterato | Maxim Group | Buy |
Mostra tutto
Abeona Therapeutics Inc Borsa (ABEO) Ultime notizie
Abeona Therapeutics Inc (ABEO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Law firm probes Abeona Therapeutics for possible director breaches harming shareholders. - Pluang
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Abeona Therapeutics Inc. (NASDAQ: ABEO) - PR Newswire
Abeona Therapeutics Inc (ABEO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ABEO|Abeona Therapeutics Inc|Price:6.050|Chg%:-0.330 - TradingKey
Abeona Therapeutics Inc (ABEO) Cash Flow - TradingKey
Abeona Therapeutics Inc (ABEO) Balance Sheet - TradingKey
Precision Trading with Abeona Therapeutics Inc. (ABEO) Risk Zones - Stock Traders Daily
Abeona Therapeutics Inc (ABEO) Institutional Confidence - TradingKey
Abeona Therapeutics Inc. ABEO Stock Forecast & Price Target - Yahoo Finance
Abeona Therapeutics (ABEO) CFO has shares withheld to cover taxes - Stock Titan
Abeona Therapeutics Inc (PCJ) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Abeona Therapeutics (ABEO) Expands Zevaskyn Access with New Trea - GuruFocus
July 2026's Leading Growth Companies With Insider Ownership - simplywall.st
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN® - The Manila Times
Cincinnati Children’s activated for rare wound gene therapy - Stock Titan
Daily Brief Health Care: JPJ (TCM) Limited(TCM), Abeona Therapeutics , Mani Inc, BioVie , Propanc Biopharma, Tivic Health Systems Inc and more - Smartkarma
Abeona Therapeutics (ABEO) Surges 3.26%: Key Levels and Potential Breakout ZoneDaily Profile - dars.gov.et
Abeona Therapeutics (NASDAQ: ABEO) shifts 760,870 warrants to SILV Fund - Stock Titan
Form 4 Abeona Therapeutics Inc For: 9 July By Investing.com - Investing.com UK
Brendan O’Malley sells $83,912 in Abeona Therapeutics stock By Investing.com - Investing.com Australia
Abeona Therapeutics CEO Seshadri Vishwas sells $473k in stock By Investing.com - Investing.com Nigeria
Abeona Therapeutics CCO Vasanthavada Madhav sells $87,784 in stock By Investing.com - Investing.com Nigeria
Abeona Therapeutics CCO Vasanthavada Madhav sells $87,784 in stock - Investing.com UK
Abeona Therapeutics CEO Seshadri Vishwas sells $473k in stock - Investing.com
Brendan O’Malley sells $83,912 in Abeona Therapeutics stock - Investing.com India
Abeona (ABEO) CFO sells 24,880 shares to cover taxes on vested stock - Stock Titan
Tax-related stock sale by Abeona (ABEO) CEO leaves 1.31M shares - Stock Titan
Abeona Therapeutics (ABEO) SVP sells shares to cover tax obligations - Stock Titan
Abeona Therapeutics (ABEO) CCO sells 12,606 shares, retains 290,623 - Stock Titan
Form 144 ABEONA THERAPEUTICS INC. For: 9 July By Investing.com - Investing.com South Africa
ABEO (NASDAQ) Form 144 shows 141,333 restricted shares planned for sale - Stock Titan
ABEO (ABEO) investor plans to sell 12,606 shares after equity award - Stock Titan
ABEO (NASDAQ: ABEO) director reports proposed stock sales in Form 144 - Stock Titan
ABEO (Nasdaq: ABEO) files Form 144: 34,230 restricted shares; insider sales noted - Stock Titan
Abeona Therapeutics CFO Vazzano sells $173,256 in common stock By Investing.com - Investing.com Nigeria
ABEO Q1 2026 Earnings: Narrowed Loss Surpasses Expectations as Stock Gains 3.82%Earnings Expansion Phase - dars.gov.et
ABEO (NASDAQ: ABEO) Rule 144 sale notice — 18,160 shares - Stock Titan
Abeona Therapeutics names Keith Goldan to board of directors - Investing.com
Price to sales forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
uniQure, Protara, Abeona, Cerebras, Verisign Insider Shake-Up - TipRanks
Insider Sell Alert: Leila Alland Sells Shares of Abeona Therapeu - GuruFocus
Abeona Therapeutics (ABEO) director Alland Leila sells 11,000 shares - Stock Titan
ABEOAbeona Therapeutics Inc Latest SEC Filings - Finviz
Technical Reactions to ABEO Trends in Macro Strategies - Stock Traders Daily
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Abeona gives 5 new hires restricted stock worth 9,000 shares - Stock Titan
Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Abeona Therapeutics Inc.(NasdaqCM: ABEO) added to Russell 2000 Value-Defensive Index - marketscreener.com
Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Abeona Therapeutics Inc Azioni (ABEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Abeona Therapeutics Inc Azioni (ABEO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Vazzano Joseph Walter | Chief Financial Officer |
Jul 09 '26 |
Sale |
6.96 |
24,880 |
173,257 |
493,557 |
| Seshadri Vishwas | Chief Executive Officer |
Jul 09 '26 |
Sale |
6.96 |
67,971 |
473,330 |
1,306,108 |
| O'Malley Brendan M. | SVP, Chief Legal Officer |
Jul 09 '26 |
Sale |
6.96 |
12,050 |
83,913 |
427,953 |
| Vasanthavada Madhav | Chief Commercial Officer |
Jul 09 '26 |
Sale |
6.96 |
12,606 |
87,784 |
290,623 |
1.84%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):